Katherine A. Eade
CIK 1721318 · last filed 2025-07-18
Katherine A. Eade is a corporate insider who has filed 19 SEC Form 4 insider transactions across 2 companies since 2017. The most recent filing, for HBIO, was dated Jul 18, 2025. Across all open-market trades the lifetime net is +$98.8K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $2.6M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$2.56M
2
19
$98.8K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| HBIO | Director | 421,126 | $6.08 | $2.56M | $98.8K | 18 | 2025-07-18 |
| Vaxxinity, Inc. (VAXX) Delisted | Director | — | $0.11 | — | $0 | 1 | 2023-06-26 |
Recent Filings
19 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-07-18 | HBIO | Grant (A) | +110,000 | $0 | EDGAR |
| 2024-05-23 | HBIO | Grant (A) | +45,872 | $0 | EDGAR |
| 2023-06-26 | Vaxxinity, Inc. (VAXX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-05-23 | HBIO | Grant (A) | +25,554 | $0 | EDGAR |
| 2022-05-26 | HBIO | Grant (A) | +38,259 | $0 | EDGAR |
| 2022-01-03 | HBIO | Grant (A) | +2,525 | $0 | EDGAR |
| 2021-12-29 | HBIO | Grant (A) | +1,401 | $0 | EDGAR |
| 2021-05-27 | HBIO | Grant (A) | +14,400 | $0 | EDGAR |
| 2021-01-06 | HBIO | Grant (A) | +14,200 | $0 | EDGAR |
| 2020-06-19 | HBIO | Grant (A) | +28,100 | $0 | EDGAR |